avanos is a medical device company focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter.headquartered in alpharetta, georgia, avanos is committed to creating the next generation of innovative healthcare solutions which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.avanos develops, manufactures and markets its recognized brands in more than 90 countries.
Company profile
Ticker
AVNS
Exchange
Website
CEO
Joseph Woody
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • MSA Safety • INVACARE • Align Technology • Surgalign • RTI Surgical ...
Former names
Halyard Health, Inc.
SEC CIK
Corporate docs
Subsidiaries
Avanos Medical (Shanghai) Co., Ltd. • Avanos Medical (Thailand) Limited • Avanos Medical Australia Pty Ltd. • Avanos Medical Belgium BVBA • Avanos Medical Brasil Consultoria Ltda. • Avanos Medical Brasilia, LLC • Avanos Medical Canada Inc. • Avanos Medical Deutschland GmbH • Avanos Medical France SAS • Avanos Medical India Private Limited ...
IRS number
464987888
AVNS stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
18 Mar 24
DEFA14A
Additional proxy soliciting materials
15 Mar 24
DEF 14A
Definitive proxy
15 Mar 24
10-K
2023 FY
Annual report
20 Feb 24
8-K
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2023 Results
20 Feb 24
8-K
Avanos Medical, Inc. Reports Preliminary Fourth Quarter and Full-Year 2023
4 Jan 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
8-K
Avanos Medical, Inc. Announces Third Quarter 2023 Results
1 Nov 23
8-K
Completion of Acquisition or Disposition of Assets
2 Oct 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
Transcripts
AVNS
Earnings call transcript
2023 Q4
20 Feb 24
AVNS
Earnings call transcript
2023 Q3
1 Nov 23
AVNS
Earnings call transcript
2023 Q2
9 Aug 23
AVNS
Earnings call transcript
2023 Q1
3 May 23
AVNS
Earnings call transcript
2022 Q4
21 Feb 23
AVNS
Earnings call transcript
2022 Q3
2 Nov 22
AVNS
Earnings call transcript
2022 Q2
13 Aug 22
AVNS
Earnings call transcript
2022 Q1
8 May 22
AVNS
Earnings call transcript
2022 Q1
4 May 22
AVNS
Earnings call transcript
2021 Q4
23 Feb 22
Latest ownership filings
4
Michael Greiner
19 Mar 24
4
Kerr Holbrook
19 Mar 24
4
Joseph Fralin Woody
19 Mar 24
4
Michael Greiner
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
Julie Ann Shimer
11 Mar 24
4
Michael Greiner
7 Mar 24
4
Kerr Holbrook
7 Mar 24
4
John Joseph Hurley
7 Mar 24
4
Mojirade James
7 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 107.10 mm | 107.10 mm | 107.10 mm | 107.10 mm | 107.10 mm | 107.10 mm |
Cash burn (monthly) | (no burn) | 825.00 k | 866.67 k | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 5.69 mm | 5.98 mm | n/a | n/a | n/a |
Cash remaining | n/a | 101.41 mm | 101.12 mm | n/a | n/a | n/a |
Runway (months of cash) | n/a | 122.9 | 116.7 | n/a | n/a | n/a |
Institutional ownership, Q3 2023
93.6% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 248 |
Opened positions | 30 |
Closed positions | 41 |
Increased positions | 69 |
Reduced positions | 82 |
13F shares | Current |
---|---|
Total value | 870.88 bn |
Total shares | 43.25 mm |
Total puts | 2.50 k |
Total calls | 1.90 k |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
BLK Blackrock | 7.13 mm | $144.24 bn |
Vanguard | 5.47 mm | $110.69 bn |
RGM Capital | 2.95 mm | $59.68 bn |
Dimensional Fund Advisors | 2.91 mm | $58.84 bn |
Paradice Investment Management | 2.27 mm | $45.96 bn |
WHG Westwood | 2.11 mm | $42.55 bn |
STT State Street | 1.99 mm | $40.23 bn |
T. Rowe Price Investment Management | 1.63 mm | $32.82 bn |
William Blair Investment Management | 1.09 mm | $22.13 bn |
Geode Capital Management | 947.75 k | $19.17 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Mar 24 | Greiner Michael | Common Stock | Payment of exercise | Dispose F | No | No | 19.09 | 7,113 | 135.79 k | 146,709 |
18 Mar 24 | Greiner Michael | Common Stock | Payment of exercise | Dispose F | No | No | 19.09 | 1,892 | 36.12 k | 153,822 |
18 Mar 24 | Greiner Michael | Common Stock | Option exercise | Acquire M | No | No | 0 | 4,219 | 0.00 | 155,714 |
18 Mar 24 | Kerr Holbrook | Common Stock | Payment of exercise | Dispose F | No | No | 19.09 | 2,840 | 54.22 k | 86,131 |
18 Mar 24 | Kerr Holbrook | Common Stock | Payment of exercise | Dispose F | No | No | 19.09 | 756 | 14.43 k | 88,971 |
18 Mar 24 | Kerr Holbrook | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,531 | 0.00 | 89,727 |
18 Mar 24 | Woody Joseph Fralin | Common Stock | Payment of exercise | Dispose F | No | No | 19.09 | 26,670 | 509.13 k | 420,045 |
18 Mar 24 | Woody Joseph Fralin | Common Stock | Payment of exercise | Dispose F | No | No | 19.09 | 7,095 | 135.44 k | 446,715 |
18 Mar 24 | Woody Joseph Fralin | Common Stock | Option exercise | Acquire M | No | No | 0 | 15,821 | 0.00 | 453,810 |
14 Mar 24 | Greiner Michael | Common Stock | Sell | Dispose S | No | No | 19.16 | 110 | 2.11 k | 151,495 |
Press releases
Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2024 Financial Results
25 Apr 24
Avanos Medical, Inc. Announces Voluntary Recall in Response to Nurse Assist, LLC Sterile Water Medical Products Recall
21 Feb 24
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2023 Financial Results
13 Feb 24